American Portfolios Advisors Lumos Pharma, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 1,250 shares of LUMO stock, worth $2,824. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,250Holding current value
$2,824% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LUMO
# of Institutions
42Shares Held
2.29MCall Options Held
0Put Options Held
0-
Wells Fargo & Company San Francisco, CA416KShares$939,1450.0% of portfolio
-
Goldman Sachs Group Inc New York, NY407KShares$918,9430.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA244KShares$551,6250.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny218KShares$492,7110.0% of portfolio
-
Acuitas Investments, LLC141KShares$317,9570.21% of portfolio
About LUMOS PHARMA, INC.
- Ticker LUMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,396,070
- Market Cap $19M
- Description
- Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...